Skip to contentS
Skinvisible, Inc.
S
SKVISkinvisible, Inc. Q3 2024 · 10-Q
Revenue$5.00K$5.00K±0.0% vs Q3 2023 Net Income-$286.60K-$286.60KN/M vs Q3 2023 EPS Diluted-$0.06-$0.06N/M vs Q3 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skinvisible, Inc. · CIK 1085277 · Engraved from SEC EDGAR
Operating Cash Flowderived-$12,542N/M Free Cash Flowderived-$12,542— Margins · derivedGross margin100.0%±0.0 pt vs Q3 2023
Operating margin-2499.4%−237.2 pt vs Q3 2023
Net margin-5732.1%+18.3 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 19, 2024 · 50 d after period end